Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fay, J. W.
Right arrow Articles by Huang, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fay, J. W.
Right arrow Articles by Huang, A. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Leukopheresis therapy of leukemic reticuloendotheliosis (hairy cell leukemia)

JW Fay, JO Moore, GL Logue and AT Huang

Intensive leukopheresis has been valuable in the short-term palliation of chronic lymphocytic and granulocytic leukemias. A 47-yr-old man with refractory leukemic reticuloendotheliosis (hairy cell leukemia) manifested by anemia, thrombocytopenia, elevated peripheral leukemia cell counts, generalized lymph node enlargement, and leukemic infiltrative skin disease was treated with serial leukopheresis. Removal of approximately 7 X 10(11) peripheral leukemia cells resulted in marked clinical and hematologic improvement with resolution of enlarged lymph nodes and clearing of skin infiltrates. At the time of this reporting, more than 400 wk since the last leukopheresis, the patient continues to do well. The improvement in all blood counts, reduction in lymph node size, and clearing of skin lesions paralleled the reduction of peripheral leukemia cell load by leukopheresis, suggesting mobilization of leukemia cells from marrow, lymph nodes, and skin. Removal of large numbers of leukemia cells in hairy cell leukemia has the potential of achieving sustained clinical improvement and may be a useful alternative therapy for these patients.

Volume 54, Issue 3, pp. 747-749, 09/01/1979
Copyright © 1979 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
B. D. CHESON and A. MARTIN
Clinical Trials in Hairy Cell Leukemia: Current Status and Future Directions
Ann Intern Med, June 1, 1987; 106(6): 871 - 878.
[Abstract] [PDF]


Home page
JAMAHome page
Council on Scientific Affairs
Current Status of Therapeutic Plasmapheresis and Related Techniques: Report of the AMA Panel on Therapeutic Plasmapheresis
JAMA, February 8, 1985; 253(6): 819 - 825.
[Abstract] [PDF]


Home page
Arch DermatolHome page
D. M. Lawrence, N. C. J. Sun, R. Mena, and R. Moss
Cutaneous Lesions in Hairy-Cell Leukemia: Case Report and Review of the Literature
Arch Dermatol, April 1, 1983; 119(4): 322 - 325.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
C. H. Mielke Jr, C. E. Dobbs, C. F. Winkler, and L. T. Yam
Therapeutic Leukapheresis in Hairy Cell Leukemia
Arch Intern Med, April 1, 1982; 142(4): 700 - 702.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1979 by American Society of Hematology         Online ISSN: 1528-0020